Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Leap Therapeutics, Inc.

TRADE

NASDAQ: LPTXHealthcare / Biotechnology / -
6.36-0.25-3.78%Vol 17 8201Y Perf 26.08%
Oct 17th, 2018 15:59
BID5.88 ASK6.80
Open6.57 Previous Close6.61
Pre-Market- After-Trading-
 - -%  - -%
Target Price
14.50 
Analyst Rating
Strong Buy 1.33
Potencial %
127.99 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)93 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
27.15 
Earnings Date
12th Nov 2018

Today's Price Range

6.316.65

 

52wk Range

4.9110.25

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-5.07%
3 Months
-23.83%
6 Months
-16.97%
1 Year
26.08%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
LPTX6.36-0.2500-3.78
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.20
Current Ratio 5.30
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -2 252.60
Leverage Ratio 3.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 7.57
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -5.10
Cash Flow Per Share -1.70
Price to Tangible Book7.57
Book Value per Share0.83
Enterprise Value (in ths.)61 398
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)128.95
ROE last 12 Months -205.96
Return on Assets (5Y Avg) -84.35
ROA last 12 Months -109.90
Return on Capital (5Y Avg) -
ROC last 12 Months -207.64
Return on invested Capital Q -52.92
Return on invested Capital Y-58.54
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.48-0.456.25
Q01 2018-0.49-0.466.12
Q04 2017-0.77-0.6515.58
Q03 2017-0.43-0.73-69.77
Q02 2017-0.50-0.74-48.00
Q01 2017-0.85-1.39-63.53
----
----
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.416.82Positive
12/2018 QR-0.446.38Positive
12/2018 FY-2.182.24Positive
12/2019 FY-1.665.14Positive
Next Report Date12th Nov 2018
Estimated EPS Next Report-0.41
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume17 820
Shares Outstanding (in ths.)14 700
Trades Count47
Dollar Volume102 058
Avg. Volume78 893
Avg. Weekly Volume46 111
Avg. Monthly Volume97 043
Avg. Quarterly Volume58 938

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

39%61%

Bearish Bullish

61%39%

Bearish Bullish

54%46%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.33

There are no comments yet.

News

x